Ghanizadeh 2008a.

Methods	A patient report of decrease in appetite during treatment with methylphenidate
Participants	Diagnosis of ADHD: DSM‐IV (subtype: not stated) Age: 8.5 years old IQ: about 100 to 110 Sex: male Ethnicity: not stated Country: Iran Comorbidity: oppositional defiant disorder Comedication: not stated Sociodemographics: not stated
Interventions	MPH dosage: 20 mg daily Administration schedule: not stated Duration of intervention: 1 month Treatment compliance: not stated
Outcomes	Non‐serious adverse events: Significant decrease in appetite
Notes	Ethics approval: informed consent was obtained Funding/vested interests: not stated Key conclusions of study authors: this report is about a child with ADHD who experienced insomnia, night terrors, and depression associated with the long‐term use of clonidine. He revealed resolution of insomnia and night terror when clonidine was removed Comments from the review authors: the adverse effects (decrease in appetite) occurred while the patient was only getting methylphenidate Supplemental information regarding IQ was retrieved through personal email communication with the author in July 2013 (Ghanizadeh 2013 [pers comm])